Avoiding Stigma and Sensationalism in Therapeutic Psilocybin Communications: Considerations for Reaching Older Patients
American Journal of Geriatric Psychiatry July 23, 2025 Charlotte M. Gillespie, Jesse M. Bering 3 citations
Older adults with treatment-resistant depression may benefit from psilocybin therapy but could hold more stigmatized views due to the drug's illicit history and past antidrug messaging. Current clinical communication may inadvertently reinforce negative attitudes. The authors offer communication guidelines for therapeutic psilocybin tailored to older patients.